Roche’s new continuous glucose monitor offers AI management for diabetic patients

Roche, a biotechnology company with a focus on diagnostics, has announced that its AI-enabled continuous glucose monitoring system has gained Conformité Européenne (CE) marking. This provides diabetic patients in Europe with a new option to measure and control their blood glucose levels, with the added benefit of an AI-powered predictive tool that can give patients a forecast of their blood glucose levels for up to two hours using a connected mobile app. This new tool could provide diabetic patients with a greater degree of blood glucose control and prevent dangerous hypoglycemic and hyperglycemic events.

Ensuring patient control of blood glucose levels is essential to managing both type 1 and type 2 diabetes. Currently, available continuous glucose monitoring systems provide real-time updates and some degree of connectivity to smartphone applications for patients’ ease of use. In addition to real-time updates, Roche’s AI innovation provides patients with two hours of glucose trends, warnings for hypoglycemia within 30 minutes, and predictions for dangerous overnight hypoglycemic events.

GlobalData forecasts that the continuous glucose monitors market will have sales of $4.7bn in 2023, increasing at a compound annual growth rate of 3.59% to $6.7bn in 2033. This market growth is fueled by the growing population of diabetics worldwide, continued demand for ease of use in the diabetic population, and new products entering the market. Innovations, such as those developed by Roche, will contribute to this growth and provide new options to the growing population of diabetics.

Roche’s innovation in continuous glucose monitoring and predictive AI provides a new, effective option for diabetics looking for greater control over their blood glucose levels. The adoption of AI in the continuous glucose monitoring space looks to be a positive force for patients, as it will reduce concerns regarding hypoglycemic episodes and provide additional information to help patients better manage their diabetes.

As the healthcare sector deals with sensitive data and critical services, cyberattacks are especially costly. And, because they are costly, they are more frequent; cybercriminals target the industries where they can do the most damage. For healthcare providers, cyberattacks can cause the exposure of sensitive patient data, care disruptions, and facility downtime, which can take weeks or months to restore and risk harm or deaths of patients. 

A 2018 study published by researchers at Vanderbilt University’s Owen Graduate School of Management found that hospitals hit by a cyberattack were likely to see up to 36 additional deaths per 10,000 heart attacks per year.